Shopping Cart 0
Cart Subtotal
AED 0

Biologics and Biosimilars Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 8368

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 9102

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 10460

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 10460

Details

According to 99Strategy, the Global Biologics and Biosimilars Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Biologics and Biosimilars market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Key Product Type

Antibody

Hormone

Growth Factors

Others

Market by Application

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Main Aspects covered in the Report

Overview of the Biologics and Biosimilars market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Table Of Content

Scope

Table of Content

1 Industrial Chain Overview

1.1 Biologics and Biosimilars Industry

1.1.1 Overview

1.1.2 Characteristics of Biologics and Biosimilars

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Antibody

1.3.2 Hormone

1.3.3 Growth Factors

1.3.4 Others

1.4 End-Use List

1.4.1 Demand in Tumor

1.4.2 Demand in Diabetes

1.4.3 Demand in Cardiovascular

1.4.4 Demand in Hemophilia

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Roche Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Amgen Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 AbbVie Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi-Aventis Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Johnson & Johnson Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Pfizer Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Novo Nordisk Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Eli Lilly Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Novartis Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Merck Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 3sbio Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Changchun High Tech Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 CP Guojian Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Biotech Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Gelgen Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Innovent Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Dong Bao Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Ganlee Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 United Laboratories Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in Antibody

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in Hormone

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in Growth Factors

5.2.3.1 Market Size

5.2.3.2 Situation & Development

5.2.4 Market in Others

5.2.4.1 Market Size

5.2.4.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Tumor

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Diabetes

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Cardiovascular

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Hemophilia

6.2.4.1 Market Size

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Biologics and Biosimilars Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in Antibody, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hormone, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Growth Factors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Tumor, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Diabetes, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Cardiovascular, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hemophilia, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Production Amount List in 2018

Table Roche Overview List

Table Biologics and Biosimilars Business Operation of Roche (Production Amount (Million USD), Cost, Gross Margin)

Table Amgen Overview List

Table Biologics and Biosimilars Business Operation of Amgen (Production Amount (Million USD), Cost, Gross Margin)

Table AbbVie Overview List

Table Biologics and Biosimilars Business Operation of AbbVie (Production Amount (Million USD), Cost, Gross Margin)

Table Sanofi-Aventis Overview List

Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Production Amount (Million USD), Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Production Amount (Million USD), Cost, Gross Margin)

Table Pfizer Overview List

Table Biologics and Biosimilars Business Operation of Pfizer (Production Amount (Million USD), Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Biologics and Biosimilars Business Operation of Novo Nordisk (Production Amount (Million USD), Cost, Gross Margin)

Table Eli Lilly Overview List

Table Biologics and Biosimilars Business Operation of Eli Lilly (Production Amount (Million USD), Cost, Gross Margin)

Table Novartis Overview List

Table Biologics and Biosimilars Business Operation of Novartis (Production Amount (Million USD), Cost, Gross Margin)

Table Merck Overview List

Table Biologics and Biosimilars Business Operation of Merck (Production Amount (Million USD), Cost, Gross Margin)

Table 3sbio Overview List

Table Biologics and Biosimilars Business Operation of 3sbio (Production Amount (Million USD), Cost, Gross Margin)

Table Changchun High Tech Overview List

Table Biologics and Biosimilars Business Operation of Changchun High Tech (Production Amount (Million USD), Cost, Gross Margin)

Table CP Guojian Overview List

Table Biologics and Biosimilars Business Operation of CP Guojian (Production Amount (Million USD), Cost, Gross Margin)

Table Biotech Overview List

Table Biologics and Biosimilars Business Operation of Biotech (Production Amount (Million USD), Cost, Gross Margin)

Table Gelgen Overview List

Table Biologics and Biosimilars Business Operation of Gelgen (Production Amount (Million USD), Cost, Gross Margin)

Table Innovent Overview List

Table Biologics and Biosimilars Business Operation of Innovent (Production Amount (Million USD), Cost, Gross Margin)

Table Dong Bao Overview List

Table Biologics and Biosimilars Business Operation of Dong Bao (Production Amount (Million USD), Cost, Gross Margin)

Table Ganlee Overview List

Table Biologics and Biosimilars Business Operation of Ganlee (Production Amount (Million USD), Cost, Gross Margin)

Table United Laboratories Overview List

Table Biologics and Biosimilars Business Operation of United Laboratories (Production Amount (Million USD), Cost, Gross Margin)

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

According to 99Strategy, the Global Biologics and Biosimilars Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Biologics and Biosimilars market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Key Product Type

Antibody

Hormone

Growth Factors

Others

Market by Application

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Main Aspects covered in the Report

Overview of the Biologics and Biosimilars market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Scope

Table of Content

1 Industrial Chain Overview

1.1 Biologics and Biosimilars Industry

1.1.1 Overview

1.1.2 Characteristics of Biologics and Biosimilars

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Antibody

1.3.2 Hormone

1.3.3 Growth Factors

1.3.4 Others

1.4 End-Use List

1.4.1 Demand in Tumor

1.4.2 Demand in Diabetes

1.4.3 Demand in Cardiovascular

1.4.4 Demand in Hemophilia

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Roche Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Amgen Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 AbbVie Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi-Aventis Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Johnson & Johnson Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Pfizer Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Novo Nordisk Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Eli Lilly Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Novartis Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Merck Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 3sbio Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Changchun High Tech Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 CP Guojian Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Biotech Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Gelgen Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Innovent Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Dong Bao Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Ganlee Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 United Laboratories Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Amount (Million USD), Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in Antibody

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in Hormone

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in Growth Factors

5.2.3.1 Market Size

5.2.3.2 Situation & Development

5.2.4 Market in Others

5.2.4.1 Market Size

5.2.4.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Tumor

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Diabetes

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Cardiovascular

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Hemophilia

6.2.4.1 Market Size

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Biologics and Biosimilars Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in Antibody, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hormone, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Growth Factors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Tumor, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Diabetes, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Cardiovascular, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hemophilia, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Production Amount List in 2018

Table Roche Overview List

Table Biologics and Biosimilars Business Operation of Roche (Production Amount (Million USD), Cost, Gross Margin)

Table Amgen Overview List

Table Biologics and Biosimilars Business Operation of Amgen (Production Amount (Million USD), Cost, Gross Margin)

Table AbbVie Overview List

Table Biologics and Biosimilars Business Operation of AbbVie (Production Amount (Million USD), Cost, Gross Margin)

Table Sanofi-Aventis Overview List

Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Production Amount (Million USD), Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Production Amount (Million USD), Cost, Gross Margin)

Table Pfizer Overview List

Table Biologics and Biosimilars Business Operation of Pfizer (Production Amount (Million USD), Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Biologics and Biosimilars Business Operation of Novo Nordisk (Production Amount (Million USD), Cost, Gross Margin)

Table Eli Lilly Overview List

Table Biologics and Biosimilars Business Operation of Eli Lilly (Production Amount (Million USD), Cost, Gross Margin)

Table Novartis Overview List

Table Biologics and Biosimilars Business Operation of Novartis (Production Amount (Million USD), Cost, Gross Margin)

Table Merck Overview List

Table Biologics and Biosimilars Business Operation of Merck (Production Amount (Million USD), Cost, Gross Margin)

Table 3sbio Overview List

Table Biologics and Biosimilars Business Operation of 3sbio (Production Amount (Million USD), Cost, Gross Margin)

Table Changchun High Tech Overview List

Table Biologics and Biosimilars Business Operation of Changchun High Tech (Production Amount (Million USD), Cost, Gross Margin)

Table CP Guojian Overview List

Table Biologics and Biosimilars Business Operation of CP Guojian (Production Amount (Million USD), Cost, Gross Margin)

Table Biotech Overview List

Table Biologics and Biosimilars Business Operation of Biotech (Production Amount (Million USD), Cost, Gross Margin)

Table Gelgen Overview List

Table Biologics and Biosimilars Business Operation of Gelgen (Production Amount (Million USD), Cost, Gross Margin)

Table Innovent Overview List

Table Biologics and Biosimilars Business Operation of Innovent (Production Amount (Million USD), Cost, Gross Margin)

Table Dong Bao Overview List

Table Biologics and Biosimilars Business Operation of Dong Bao (Production Amount (Million USD), Cost, Gross Margin)

Table Ganlee Overview List

Table Biologics and Biosimilars Business Operation of Ganlee (Production Amount (Million USD), Cost, Gross Margin)

Table United Laboratories Overview List

Table Biologics and Biosimilars Business Operation of United Laboratories (Production Amount (Million USD), Cost, Gross Margin)

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS